|
FR2754177B1
(fr)
*
|
1996-10-07 |
1999-08-06 |
Sanofi Sa |
Microspheres pharmaceutiques d'acide valproique pour administration orale
|
|
DE19809719A1
(de)
|
1998-03-06 |
1999-09-09 |
Roehm Gmbh |
Wäßrige Dispersion geeignet zur Herstellung von Überzugs- und Bindemitteln für feste orale Arzneiformen
|
|
DE19845358A1
(de)
*
|
1998-10-02 |
2000-04-06 |
Roehm Gmbh |
Überzogene Arzneiformen mit kontrollierter Wirkstoffabgabe
|
|
CA2361496C
(en)
*
|
1999-02-04 |
2011-06-07 |
Abbott Laboratories |
Ph independent extended release pharmaceutical formulation
|
|
EP1064938A1
(en)
*
|
1999-06-28 |
2001-01-03 |
Sanofi-Synthelabo |
Pharmaceutical dosage forms for controlled release producing at least a timed pulse
|
|
CZ20022294A3
(cs)
*
|
1999-12-28 |
2002-11-13 |
Ajinomoto Co., Inc. |
Antidiabetický preparát k orálnímu uľití
|
|
HUP0302466A2
(hu)
*
|
2000-02-29 |
2003-11-28 |
Teva Pharmaceutical Industries Ltd. |
Eljárások clarithromycin, clarithromycin intermedier, gyakorlatilag oximmentes clarithromycin és ezt tartalmazó gyógyszerkészítmény előállítására
|
|
FR2826274B1
(fr)
*
|
2001-06-21 |
2003-09-26 |
Aventis Pharma Sa |
Formulation pharmaceutique au gout masque et son procede de preparation
|
|
EP1469833B1
(en)
|
2002-02-01 |
2021-05-19 |
Bend Research, Inc. |
Method for making homogeneous spray-dried solid amorphous drug dispersions utilizing modified spray-drying apparatus
|
|
NZ534746A
(en)
*
|
2002-03-12 |
2006-06-30 |
Bristol Myers Squibb Co |
Palatable oral suspension and method
|
|
US6930119B2
(en)
*
|
2002-07-17 |
2005-08-16 |
Reliant Pharmaceuticals, Inc. |
Liquid pharmaceutical composition
|
|
CN1703200B
(zh)
*
|
2002-09-20 |
2012-02-29 |
奥尔制药公司 |
隔离亚单元和相关组合物及方法
|
|
US20040091544A1
(en)
*
|
2002-11-08 |
2004-05-13 |
Ruff Michael D. |
Coated dibasic calcium phosphate
|
|
US20040170686A1
(en)
*
|
2003-01-31 |
2004-09-02 |
Fredrickson Jennifer K. |
Suspension vehicle for coated drug particles
|
|
US20040186180A1
(en)
|
2003-03-21 |
2004-09-23 |
Gelotte Cathy K. |
Non-steroidal anti-inflammatory drug dosing regimen
|
|
US20040191326A1
(en)
*
|
2003-03-31 |
2004-09-30 |
Reo Joseph P. |
Taste-masking vehicle for coated oxazolidinone particles
|
|
CA2529429C
(en)
*
|
2003-06-17 |
2009-10-20 |
Filtertek Inc. |
Fluid handling device and method of making same
|
|
CL2004001884A1
(es)
*
|
2003-08-04 |
2005-06-03 |
Pfizer Prod Inc |
Procedimiento de secado por pulverizacion para la formacion de dispersiones solidas amorfas de un farmaco y polimeros.
|
|
US20050137262A1
(en)
*
|
2003-12-22 |
2005-06-23 |
Hu Patrick C. |
Highly concentrated pourable aqueous solutions of potassium ibuprofen, their preparation and their uses
|
|
US20050163843A1
(en)
*
|
2003-12-31 |
2005-07-28 |
Garth Boehm |
Alprazolam formulations
|
|
AU2004312059A1
(en)
*
|
2003-12-31 |
2005-07-21 |
Actavis Group Hf |
Atomoxetine formulations
|
|
WO2005065662A1
(en)
*
|
2003-12-31 |
2005-07-21 |
Actavis Group Hf |
Solid dosage formulations of galantamine
|
|
WO2005065645A2
(en)
*
|
2003-12-31 |
2005-07-21 |
Actavis Group Hf |
Donepezil formulations
|
|
WO2005065663A1
(en)
*
|
2003-12-31 |
2005-07-21 |
Alpharma, Inc. |
Rosiglitazone and metformin formulations
|
|
WO2005065654A2
(en)
*
|
2003-12-31 |
2005-07-21 |
Alpharma, Inc. |
Rosiglitazone formulations
|
|
EP1703898A2
(en)
*
|
2003-12-31 |
2006-09-27 |
Alpharma, Inc. |
Ziprasidone formulations
|
|
CA2551946A1
(en)
*
|
2003-12-31 |
2005-07-21 |
Actavis Group Hf |
Immediate, controlled and sustained release formulations of galantamine
|
|
CN101123951A
(zh)
|
2004-08-31 |
2008-02-13 |
辉瑞产品公司 |
包括低溶解性药物和聚合物的药物剂型
|
|
GB2419094A
(en)
*
|
2004-10-12 |
2006-04-19 |
Sandoz Ag |
Pharmaceutical composition of unpleasnt tasing active substances
|
|
US7378109B2
(en)
*
|
2004-12-23 |
2008-05-27 |
Council Of Scientific And Industrial Research |
Pharmaceutical composition for improving palatability of drugs and process for preparation thereof
|
|
CA2598668A1
(en)
*
|
2005-02-25 |
2006-09-08 |
Mutual Pharmaceutical Company, Inc. |
Dosage forms of antibiotics and combinations of antibiotics and symptomatic relief agents
|
|
US20060264458A1
(en)
*
|
2005-05-03 |
2006-11-23 |
Jie Du |
Quinine dosage forms and methods of use thereof
|
|
CN1883456B
(zh)
*
|
2005-06-20 |
2010-12-15 |
常州市第四制药厂有限公司 |
掩味药物颗粒及其制备方法和用途
|
|
JP2007031407A
(ja)
*
|
2005-07-29 |
2007-02-08 |
Shin Etsu Chem Co Ltd |
低置換度セルロースエーテル含有コーティング用組成物及び不快な味が隠蔽されたフィルムコーティング製剤
|
|
US20070087056A1
(en)
*
|
2005-08-09 |
2007-04-19 |
Claudia Guthmann |
Pharmaceutical form with sustained pH-independent active ingredient release for active ingredients having strong pH-dependent solubility
|
|
US9101160B2
(en)
|
2005-11-23 |
2015-08-11 |
The Coca-Cola Company |
Condiments with high-potency sweetener
|
|
BRPI0709382A2
(pt)
*
|
2006-03-16 |
2011-07-12 |
Novartis Ag |
forma de dosagem sólida contendo um agente ativo de sabor mascarado
|
|
JP4892264B2
(ja)
*
|
2006-03-30 |
2012-03-07 |
高田製薬株式会社 |
リスペリドン水性液剤
|
|
SI2719378T1
(sl)
*
|
2006-06-19 |
2016-11-30 |
Alpharma Pharmaceuticals Llc |
Farmacevtski sestavki
|
|
US7915247B1
(en)
|
2006-08-21 |
2011-03-29 |
Mutual Pharmaceutical Company, Inc. |
Methods of use of fenofibric acid
|
|
US20080233156A1
(en)
*
|
2006-10-11 |
2008-09-25 |
Alpharma, Inc. |
Pharmaceutical compositions
|
|
US8017168B2
(en)
|
2006-11-02 |
2011-09-13 |
The Coca-Cola Company |
High-potency sweetener composition with rubisco protein, rubiscolin, rubiscolin derivatives, ace inhibitory peptides, and combinations thereof, and compositions sweetened therewith
|
|
WO2008065502A1
(en)
*
|
2006-11-29 |
2008-06-05 |
Pfizer Products Inc. |
Pharmaceutical compositions based on a) nanoparticles comprising enteric polymers and b) casein
|
|
TW200835527A
(en)
*
|
2006-12-26 |
2008-09-01 |
Shionogi & Co |
Orally disintegrating tablet and bitter taste-masked formulation comprising risperidone
|
|
JP4941977B2
(ja)
*
|
2007-04-11 |
2012-05-30 |
大蔵製薬株式会社 |
ベンズイソキサゾール誘導体の経口ゼリー状医薬組成物
|
|
US20100119612A1
(en)
*
|
2007-04-17 |
2010-05-13 |
Bend Research, Inc |
Nanoparticles comprising non-crystalline drug
|
|
WO2008135828A2
(en)
*
|
2007-05-03 |
2008-11-13 |
Pfizer Products Inc. |
Nanoparticles comprising a drug, ethylcellulose, and a bile salt
|
|
WO2008135855A2
(en)
*
|
2007-05-03 |
2008-11-13 |
Pfizer Products Inc. |
Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and a nonionizable polymer
|
|
WO2008135852A2
(en)
*
|
2007-05-03 |
2008-11-13 |
Pfizer Products Inc. |
Pharmaceutical compositions comprising nanoparticles and casein
|
|
EP2162120B1
(en)
*
|
2007-06-04 |
2016-05-04 |
Bend Research, Inc |
Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable block copolymer
|
|
US9545384B2
(en)
|
2007-06-04 |
2017-01-17 |
Bend Research, Inc. |
Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glocol succinate
|
|
US20100215747A1
(en)
*
|
2007-07-13 |
2010-08-26 |
Corey Jay Bloom |
Nanoparticles comprising ionizable, poorly water soluble cellulosic polymers
|
|
WO2009073215A1
(en)
*
|
2007-12-06 |
2009-06-11 |
Bend Research, Inc. |
Pharmaceutical compositions comprising nanoparticles and a resuspending material
|
|
US9233078B2
(en)
*
|
2007-12-06 |
2016-01-12 |
Bend Research, Inc. |
Nanoparticles comprising a non-ionizable polymer and an Amine-functionalized methacrylate copolymer
|
|
US8623418B2
(en)
*
|
2007-12-17 |
2014-01-07 |
Alpharma Pharmaceuticals Llc |
Pharmaceutical composition
|
|
AU2008346870A1
(en)
*
|
2007-12-17 |
2009-07-16 |
Alpharma Pharmaceuticals, Llc |
Pharmaceutical composition
|
|
HUE030830T2
(en)
|
2009-03-27 |
2017-06-28 |
Toray Industries |
Covered solid preparation
|
|
US20110150986A1
(en)
*
|
2009-12-18 |
2011-06-23 |
Kristin Arnold |
Quinine formulations, method of making, and metho of use thereof
|
|
US20110223244A1
(en)
*
|
2010-03-09 |
2011-09-15 |
Elan Pharma International Limited |
Alcohol resistant enteric pharmaceutical compositions
|
|
WO2013156163A1
(en)
|
2012-04-19 |
2013-10-24 |
Glatt Ag |
Taste-masked pharmaceutical compositions containing diclofenac
|
|
ES2821528T3
(es)
|
2012-11-14 |
2021-04-26 |
Grace W R & Co |
Composiciones que contienen un material biológicamente activo y un óxido inorgánico no ordenado
|
|
WO2017057884A1
(ko)
*
|
2015-09-30 |
2017-04-06 |
(주)아모레퍼시픽 |
자가회복 가능한 코어-쉘 캡슐
|
|
US9463183B1
(en)
|
2015-10-30 |
2016-10-11 |
Silvergate Pharmaceuticals, Inc. |
Lisinopril formulations
|
|
WO2020011938A1
(en)
|
2018-07-11 |
2020-01-16 |
Medizinische Universität Wien |
Glucocorticoids for the topical treatment of autoimmune gastritis
|
|
CN113181133A
(zh)
*
|
2021-04-25 |
2021-07-30 |
海南通用三洋药业有限公司 |
一种罗红霉素胶囊的制备方法
|
|
CN116687843B
(zh)
*
|
2022-12-16 |
2026-03-20 |
中国人民解放军军事科学院军事医学研究院 |
一种高稳定性的布瓦西坦溶液及其制备方法和其应用
|
|
WO2026018141A1
(en)
*
|
2024-07-15 |
2026-01-22 |
Callidus Research Laboratories Private Limited. |
A stable ready to use suspension of empagliflozin
|